Copyright Reports & Markets. All rights reserved.

Global Tumor Cell Isolation Kits Market Growth (Status and Outlook) 2022-2028

Request for Sample of this report
Buy now

1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Tumor Cell Isolation Kits Market Size 2017-2028
    • 2.1.2 Tumor Cell Isolation Kits Market Size CAGR by Region 2017 VS 2022 VS 2028
  • 2.2 Tumor Cell Isolation Kits Segment by Type
    • 2.2.1 Breast Cancer Tumor Cell Isolation
    • 2.2.2 Melanoma Tumor Cell Isolation
    • 2.2.3 Ovarian Cancer Tumor Cell Isolation
    • 2.2.4 Others
  • 2.3 Tumor Cell Isolation Kits Market Size by Type
    • 2.3.1 Tumor Cell Isolation Kits Market Size CAGR by Type (2017 VS 2022 VS 2028)
    • 2.3.2 Global Tumor Cell Isolation Kits Market Size Market Share by Type (2017-2022)
  • 2.4 Tumor Cell Isolation Kits Segment by Application
    • 2.4.1 Diagnostic Laboratories
    • 2.4.2 Hospitals
    • 2.4.3 Specialty Clinics
    • 2.4.4 Research Laboratories
    • 2.4.5 Others
  • 2.5 Tumor Cell Isolation Kits Market Size by Application
    • 2.5.1 Tumor Cell Isolation Kits Market Size CAGR by Application (2017 VS 2022 VS 2028)
    • 2.5.2 Global Tumor Cell Isolation Kits Market Size Market Share by Application (2017-2022)

3 Tumor Cell Isolation Kits Market Size by Player

  • 3.1 Tumor Cell Isolation Kits Market Size Market Share by Players
    • 3.1.1 Global Tumor Cell Isolation Kits Revenue by Players (2020-2022)
    • 3.1.2 Global Tumor Cell Isolation Kits Revenue Market Share by Players (2020-2022)
  • 3.2 Global Tumor Cell Isolation Kits Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
    • 3.3.1 Competition Landscape Analysis
    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion

4 Tumor Cell Isolation Kits by Regions

  • 4.1 Tumor Cell Isolation Kits Market Size by Regions (2017-2022)
  • 4.2 Americas Tumor Cell Isolation Kits Market Size Growth (2017-2022)
  • 4.3 APAC Tumor Cell Isolation Kits Market Size Growth (2017-2022)
  • 4.4 Europe Tumor Cell Isolation Kits Market Size Growth (2017-2022)
  • 4.5 Middle East & Africa Tumor Cell Isolation Kits Market Size Growth (2017-2022)

5 Americas

  • 5.1 Americas Tumor Cell Isolation Kits Market Size by Country (2017-2022)
  • 5.2 Americas Tumor Cell Isolation Kits Market Size by Type (2017-2022)
  • 5.3 Americas Tumor Cell Isolation Kits Market Size by Application (2017-2022)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Tumor Cell Isolation Kits Market Size by Region (2017-2022)
  • 6.2 APAC Tumor Cell Isolation Kits Market Size by Type (2017-2022)
  • 6.3 APAC Tumor Cell Isolation Kits Market Size by Application (2017-2022)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia

7 Europe

  • 7.1 Europe Tumor Cell Isolation Kits by Country (2017-2022)
  • 7.2 Europe Tumor Cell Isolation Kits Market Size by Type (2017-2022)
  • 7.3 Europe Tumor Cell Isolation Kits Market Size by Application (2017-2022)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Tumor Cell Isolation Kits by Region (2017-2022)
  • 8.2 Middle East & Africa Tumor Cell Isolation Kits Market Size by Type (2017-2022)
  • 8.3 Middle East & Africa Tumor Cell Isolation Kits Market Size by Application (2017-2022)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Global Tumor Cell Isolation Kits Market Forecast

  • 10.1 Global Tumor Cell Isolation Kits Forecast by Regions (2023-2028)
    • 10.1.1 Global Tumor Cell Isolation Kits Forecast by Regions (2023-2028)
    • 10.1.2 Americas Tumor Cell Isolation Kits Forecast
    • 10.1.3 APAC Tumor Cell Isolation Kits Forecast
    • 10.1.4 Europe Tumor Cell Isolation Kits Forecast
    • 10.1.5 Middle East & Africa Tumor Cell Isolation Kits Forecast
  • 10.2 Americas Tumor Cell Isolation Kits Forecast by Country (2023-2028)
    • 10.2.1 United States Tumor Cell Isolation Kits Market Forecast
    • 10.2.2 Canada Tumor Cell Isolation Kits Market Forecast
    • 10.2.3 Mexico Tumor Cell Isolation Kits Market Forecast
    • 10.2.4 Brazil Tumor Cell Isolation Kits Market Forecast
  • 10.3 APAC Tumor Cell Isolation Kits Forecast by Region (2023-2028)
    • 10.3.1 China Tumor Cell Isolation Kits Market Forecast
    • 10.3.2 Japan Tumor Cell Isolation Kits Market Forecast
    • 10.3.3 Korea Tumor Cell Isolation Kits Market Forecast
    • 10.3.4 Southeast Asia Tumor Cell Isolation Kits Market Forecast
    • 10.3.5 India Tumor Cell Isolation Kits Market Forecast
    • 10.3.6 Australia Tumor Cell Isolation Kits Market Forecast
  • 10.4 Europe Tumor Cell Isolation Kits Forecast by Country (2023-2028)
    • 10.4.1 Germany Tumor Cell Isolation Kits Market Forecast
    • 10.4.2 France Tumor Cell Isolation Kits Market Forecast
    • 10.4.3 UK Tumor Cell Isolation Kits Market Forecast
    • 10.4.4 Italy Tumor Cell Isolation Kits Market Forecast
    • 10.4.5 Russia Tumor Cell Isolation Kits Market Forecast
  • 10.5 Middle East & Africa Tumor Cell Isolation Kits Forecast by Region (2023-2028)
    • 10.5.1 Egypt Tumor Cell Isolation Kits Market Forecast
    • 10.5.2 South Africa Tumor Cell Isolation Kits Market Forecast
    • 10.5.3 Israel Tumor Cell Isolation Kits Market Forecast
    • 10.5.4 Turkey Tumor Cell Isolation Kits Market Forecast
    • 10.5.5 GCC Countries Tumor Cell Isolation Kits Market Forecast
  • 10.6 Global Tumor Cell Isolation Kits Forecast by Type (2023-2028)
  • 10.7 Global Tumor Cell Isolation Kits Forecast by Application (2023-2028)

11 Key Players Analysis

  • 11.1 Thermo Fisher Scientific
    • 11.1.1 Thermo Fisher Scientific Company Information
    • 11.1.2 Thermo Fisher Scientific Tumor Cell Isolation Kits Product Offered
    • 11.1.3 Thermo Fisher Scientific Tumor Cell Isolation Kits Revenue, Gross Margin and Market Share (2020-2022)
    • 11.1.4 Thermo Fisher Scientific Main Business Overview
    • 11.1.5 Thermo Fisher Scientific Latest Developments
  • 11.2 Miltenyi Biotec
    • 11.2.1 Miltenyi Biotec Company Information
    • 11.2.2 Miltenyi Biotec Tumor Cell Isolation Kits Product Offered
    • 11.2.3 Miltenyi Biotec Tumor Cell Isolation Kits Revenue, Gross Margin and Market Share (2020-2022)
    • 11.2.4 Miltenyi Biotec Main Business Overview
    • 11.2.5 Miltenyi Biotec Latest Developments
  • 11.3 Cell Biolabs, Inc.
    • 11.3.1 Cell Biolabs, Inc. Company Information
    • 11.3.2 Cell Biolabs, Inc. Tumor Cell Isolation Kits Product Offered
    • 11.3.3 Cell Biolabs, Inc. Tumor Cell Isolation Kits Revenue, Gross Margin and Market Share (2020-2022)
    • 11.3.4 Cell Biolabs, Inc. Main Business Overview
    • 11.3.5 Cell Biolabs, Inc. Latest Developments
  • 11.4 STEMCELL Technologies Inc.
    • 11.4.1 STEMCELL Technologies Inc. Company Information
    • 11.4.2 STEMCELL Technologies Inc. Tumor Cell Isolation Kits Product Offered
    • 11.4.3 STEMCELL Technologies Inc. Tumor Cell Isolation Kits Revenue, Gross Margin and Market Share (2020-2022)
    • 11.4.4 STEMCELL Technologies Inc. Main Business Overview
    • 11.4.5 STEMCELL Technologies Inc. Latest Developments
  • 11.5 QIAGEN
    • 11.5.1 QIAGEN Company Information
    • 11.5.2 QIAGEN Tumor Cell Isolation Kits Product Offered
    • 11.5.3 QIAGEN Tumor Cell Isolation Kits Revenue, Gross Margin and Market Share (2020-2022)
    • 11.5.4 QIAGEN Main Business Overview
    • 11.5.5 QIAGEN Latest Developments
  • 11.6 Genekam
    • 11.6.1 Genekam Company Information
    • 11.6.2 Genekam Tumor Cell Isolation Kits Product Offered
    • 11.6.3 Genekam Tumor Cell Isolation Kits Revenue, Gross Margin and Market Share (2020-2022)
    • 11.6.4 Genekam Main Business Overview
    • 11.6.5 Genekam Latest Developments
  • 11.7 Menarini Silicon Biosystems, Inc.
    • 11.7.1 Menarini Silicon Biosystems, Inc. Company Information
    • 11.7.2 Menarini Silicon Biosystems, Inc. Tumor Cell Isolation Kits Product Offered
    • 11.7.3 Menarini Silicon Biosystems, Inc. Tumor Cell Isolation Kits Revenue, Gross Margin and Market Share (2020-2022)
    • 11.7.4 Menarini Silicon Biosystems, Inc. Main Business Overview
    • 11.7.5 Menarini Silicon Biosystems, Inc. Latest Developments

12 Research Findings and Conclusion

The global market for Tumor Cell Isolation Kits is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

The APAC Tumor Cell Isolation Kits market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The United States Tumor Cell Isolation Kits market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The Europe Tumor Cell Isolation Kits market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The China Tumor Cell Isolation Kits market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

Global key Tumor Cell Isolation Kits players cover Thermo Fisher Scientific, Miltenyi Biotec, Cell Biolabs, Inc., STEMCELL Technologies Inc. and QIAGEN, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

Report Coverage
This latest report provides a deep insight into the global Tumor Cell Isolation Kits market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.

This report aims to provide a comprehensive picture of the global Tumor Cell Isolation Kits market, with both quantitative and qualitative data, to help readers understand how the Tumor Cell Isolation Kits market scenario changed across the globe during the pandemic and Russia-Ukraine War.

The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.

Market Segmentation:
The study segments the Tumor Cell Isolation Kits market and forecasts the market size by Type (Breast Cancer Tumor Cell Isolation, Melanoma Tumor Cell Isolation and Ovarian Cancer Tumor Cell Isolation), by Application (Diagnostic Laboratories, Hospitals, Specialty Clinics and Research Laboratories), and region (APAC, Americas, Europe, and Middle East & Africa).

Segmentation by type
Breast Cancer Tumor Cell Isolation
Melanoma Tumor Cell Isolation
Ovarian Cancer Tumor Cell Isolation
Others

Segmentation by application
Diagnostic Laboratories
Hospitals
Specialty Clinics
Research Laboratories
Others

Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Major companies covered
Thermo Fisher Scientific
Miltenyi Biotec
Cell Biolabs, Inc.
STEMCELL Technologies Inc.
QIAGEN
Genekam
Menarini Silicon Biosystems, Inc.

Chapter Introduction
Chapter 1: Scope of Tumor Cell Isolation Kits, Research Methodology, etc.
Chapter 2: Executive Summary, global Tumor Cell Isolation Kits market size and CAGR, Tumor Cell Isolation Kits market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Tumor Cell Isolation Kits revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Tumor Cell Isolation Kits revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Tumor Cell Isolation Kits market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Thermo Fisher Scientific, Miltenyi Biotec, Cell Biolabs, Inc., STEMCELL Technologies Inc., QIAGEN, Genekam and Menarini Silicon Biosystems, Inc., etc.
Chapter 14: Research Findings and Conclusion
Buy now